Jason Paul Steik - 17 Apr 2025 Form 3 Insider Report for Pennant Group, Inc. (PNTG)

Role
Chief Clinical Officer
Signature
/s/ Kirk Cheney, as attorney in fact
Issuer symbol
PNTG
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
3
Filing time
31 Jul 2025, 11:49:30 UTC
Next filing
12 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Steik Jason Paul Chief Clinical Officer 1675 E. RIVERSIDE DR, SUITE 150, EAGLE /s/ Kirk Cheney, as attorney in fact 31 Jul 2025 0002078374

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PNTG Common Stock 16,500 17 Apr 2025 Direct
holding PNTG Common Stock 647 17 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 2,500 $37.70 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 5,000 $38.88 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 5,000 $31.54 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 3,000 $24.04 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 2,000 $14.13 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 25,000 $15.02 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 5,000 $12.52 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 20,000 $18.79 Direct F2
holding PNTG Stock Option (right to buy) 17 Apr 2025 Common Stock 35,000 $30.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein were acquired through open market purchases prior to the date the reporting person became an Officer of the Issuer.
F2 The awards vest in five equal annual installments beginning on the first anniversary of the date of the grant.